Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Nature Communications|October 27, 2022
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinomaJens Bauer, Natalie Köhler, Yacine Maringer, et al.
Blood Cancer Discovery|October 17, 2023
Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor CellsAnnika Nelde, Heiko Schuster, Jonas S Heitmann, et al.
Nature Communications|February 10, 2023
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapyJenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, et al.
Cancer Research|June 17, 2024
Oncogenic Calreticulin Induces Immune Escape by Stimulating TGFβ Expression and Regulatory T-cell Expansion in the Bone Marrow MicroenvironmentDominik Schmidt, Cornelia Endres, Rouven Hoefflin, et al.
The Lancet. Haematology|January 17, 2026
Personalised multipeptide-based T-cell activator for chronic lymphocytic leukaemia: an open-label, single-centre, phase 1 studyJonas S Heitmann, Yacine Maringer, Susanne Jung, et al.
The Journal of Clinical Investigation|April 28, 2020
Loss of the Fanconi anemia-associated protein NIPA causes bone marrow failureStefanie Kreutmair, Miriam Erlacher, Geoffroy Andrieux, et al.
Cancer Research|October 3, 2025
FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid LeukemiaMelissa Zwick, Bastian Zinkel, Corinna Spohr, et al.
Blood|October 27, 2025
Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AMLViktor Fetsch, Lennard Frederik Schwöbel, Ezgi Ozyerli-Goknar, et al.
The Journal of Clinical Investigation|June 25, 2024
Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in miceNana Talvard-Balland, Lukas M Braun, Karen O Dixon, et al.
Cancer Cell|February 11, 2025
Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunityLukas M Braun, Sophie Giesler, Geoffroy Andrieux, et al.
Pageof 2